Patents by Inventor Brigitte Renoux

Brigitte Renoux has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NEW THERAPEUTIC VECTORS AND PRODRUGS FOR TREATING CANCERS
    Publication number: 20220227741
    Abstract: The present invention relates to a compound having the following formula (I): as well as the corresponding prodrugs, pharmaceutical compositions comprising said compounds, in particular for treating cancer.
    Type: Application
    Filed: May 6, 2020
    Publication date: July 21, 2022
    Inventors: Sébastien PAPOT, Brigitte RENOUX, Rémi CHATRE
  • Conjugates and prodrugs for treating cancer and inflammatory diseases
    Patent number: 10293021
    Abstract: The present invention relates to the field of cancer and inflammatory diseases. More particularly, it aims to provide, for these purposes, novel conjugated forms of active ingredients belonging to the dolastatin family and having the formula as follows: It is also directed towards prodrug forms of these conjugates.
    Type: Grant
    Filed: February 6, 2015
    Date of Patent: May 21, 2019
    Assignees: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, UNIVERSITE DE POITIERS
    Inventors: Sebastien Papot, Isabelle Opalinski, Brigitte Renoux, Thibaut Legigan
  • CONJUGATES AND PRODRUGS FOR TREATING OF CANCER AND INFLAMMATORY DISEASES
    Publication number: 20170095525
    Abstract: The present invention relates to the field of cancer and inflammatory diseases. More particularly, it aims to provide, for these purposes, novel conjugated forms of active ingredients belonging to the dolastatin family and having the formula as follows: It is also directed towards prodrug forms of these conjugates.
    Type: Application
    Filed: February 6, 2015
    Publication date: April 6, 2017
    Inventors: Sebastien Papot, Isabelle OPALINSKI, Brigitte RENOUX, Thibaut LEGIGAN
  • Glycosylated prodrugs, their method of preparation and their uses
    Patent number: 5561119
    Abstract: Glycosylated prodrugs, a preparation method therefor, and their use with tumor-specific immunoenzymatic conjugates for the treatment of cancer, are described. These anthracycline prodrugs have formula (I).
    Type: Grant
    Filed: May 27, 1994
    Date of Patent: October 1, 1996
    Assignees: Laboratoires Hoechst, Behringwerke A.G.
    Inventors: Jean-Claude Jacquesy, Jean-Pierre Gesson, Claude Monneret, Martine Mondon, Brigitte Renoux, Jean-Claude Florent, Michel Koch, Fran.cedilla.ois Tillequin, Hans H. Sedlacek, Manfred Gerken, Cenek Kolar, Gilbert Gaudel, Klaus Bosslet, J org Czech, Dieter Hoffman, Gerhard Seemann, Hans-Ulrich Schorlemmer, Gerhard Dickneite